Using organ-on-a-chip platform, researchers devise potential strategy to treat severe COVID-19 complications

Using their novel organ-on-a-chip platform, a research team from the University of Toronto's Faculty of Applied Science & Engineering has identified a molecule with the potential to combat one of the most severe complications of COVID-19 infections.
Using their novel organ-on-a-chip platform, a research team from the University of Toronto’s Faculty of Applied Science & Engineering has identified a molecule with the potential to combat one of the most severe complications of COVID-19 infections.